Heterogeneity of outcomes within diabetic patients with atrial fibrillation on edoxaban: a sub-analysis from the ETNA-AF Europe registry

BACKGROUND: Recent data have suggested that insulin-requiring diabetes mostly contributes to the overall increase of thromboembolic risk in patients with atrial fibrillation (AF) on warfarin. We evaluated the prognostic role of a different diabetes status on clinical outcome in a large cohort of AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Patti, Giuseppe, Pecen, Ladislav, Casalnuovo, Giuseppina, Manu, Marius Constantin, Kirchhof, Paulus, De Caterina, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584730/
https://www.ncbi.nlm.nih.gov/pubmed/35976428
http://dx.doi.org/10.1007/s00392-022-02080-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584730/
https://www.ncbi.nlm.nih.gov/pubmed/35976428
http://dx.doi.org/10.1007/s00392-022-02080-5

Ejemplares similares